Related Experiment Video
Updated: Feb 12, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
Model-Informed Drug Development and Review for Generic Products: Summary of FDA Public Workshop
Lanyan Fang1, Myong-Jin Kim1, Zhichuan Li1
1Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Abstract:
On October 2nd and 3rd , 2017, the US Food and Drug Administration (FDA) hosted a public workshop titled "Leveraging Quantitative Methods and Modeling to Modernize Generic Drug Development and Review."1 This report summarizes Session 2 of the public workshop: "Model Informed Drug Development and Review for Generic Products." The session focused on the application of quantitative methods and modeling in modernizing the generic drug development and review.
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
5-Number Summary
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Drug Product Stability
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview

